←
Greninger Lab150 posts
Greninger Lab avatar

Greninger Lab

@GreningerLab

Head, Infectious Disease Diagnostics Division at University of Washington. Infectious Diseases Research, Clinical Trials, and Testing. @uwlabmedpath @UWVirology

◷ Joined February 2019▧ 5 Photos and videos
Greninger Lab avatar
Greninger Lab@GreningerLab·Aug 2

Just signed the validation documents for our Monday launch of clinical quantitative Hepatitis B surface antigen (qHBsAg) testing at UW! (test code: HBSAGQ) qHBsAg is a fascinating analyte. It's the main eligibility criterion as well as primary outcome measure for HBV antiviral trials. The definition of functional cure in global guidelines. Approved in other countries for more than 15 years. But it was the poster child of a vicious cycle in diagnostic testing (no indication -> no FDA authorized test -> no testing -> no awareness). That all seems ready to change with the recent banger of clinical trial results for GSK's bepirovirsen reported in May (nejm.org/doi/full/10.1056/NE…). 20% of treated participants of functional cure for HBV compared to nobody in the placebo groups. Independently replicated in two cohorts. It's not quite sofosbuvir-level news, but what an opening for HBV cure. Anyway, back to the lab. Only half of people with HBV in the United States know they're infected and essentially no one knows their qHBsAg level and whether they could be eligible for this drug when it's approved. We've got to catch up quick (you can see GSK try here, usmahepa.gskusmedicalaffairs…). But there are no FDA-authorized qHBsAg tests available and won't be for many months. Enter the laboratory-developed test for qHBsAg. UW has performed qHBsAg testing for clinical trials for more than a decade, first for the NIH Hepatitis B Research Network and now for the Advancing Clinical Trials Globally Network. It's great to finally be able to make this test more widely available.

UW Medicine Newsroom avatar
⟳ Greninger Lab retweeted
UW Medicine Newsroom@uwmnewsroom·Jun 9

Efforts are underway @UWMedicine to streamline Western Blot genital herpes test interpretation. Scientific American's @sciam Lauren Schneider spoke with @uwlabmedpath's virus experts Alex Greninger @GreningerLab & Pavitra Roychoudhury @pavitrarc tinyurl.com/28rfzkv4

Keith Robison avatar
⟳ Greninger Lab retweeted
Keith Robison@OmicsOmicsBlog·Jun 1

The BioFire diagnostic PCR system has a high false positive rate for norovirus in 2024 So this group cracked open some BioFire PCR pouches and sequenced the amplicon in Norovirus positives Poor amplicon design - amplified of common enteric bacteria medrxiv.org/content/10.64898…

NEJM avatar
⟳ Greninger Lab retweeted
NEJM@NEJM·Feb 25

Mpox continues to spread in many communities. Tecovirimat has activity against orthopoxviruses in vitro. In a phase 3 trial involving patients with acute mpox, tecovirimat showed no evidence of clinical activity. Full STOMP/A5418 trial results: https://nej.md/4rdlMA9

Post attachment
Greninger Lab avatar
Greninger Lab@GreningerLab·Jan 25

New biorxiv on the discovery of an anellovirus genome integrated into an acute myeloid leukemia cell line that’s been used for 30+ years. The discovery informs blood cell tropism of anelloviruses and let us profile cancer systems biology data to inform anellovirus transcription.

Integration of an anellovirus genome in the SKNO-1 acute myeloid leukemia cell line biorxiv.org/content/10.64898… #biorxiv_genomic

David Bacsik avatar
⟳ Greninger Lab retweeted
David Bacsik@dbacsik·19 Mar 2025

1/ How has H5N1 affected this year’s flu season in Seattle? Despite ongoing outbreaks in birds & cattle nationally, we detected zero H5N1 cases in 675 influenza A-positive specimens tested at UW Medicine.